ATB Therapeutics is a startup based in Germany, most recent round Seed, 1 tracked investor.
ATB Therapeutics is a startup founded in 2020 based in Germany. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
ATB Therapeutics is a biotech company developing next-generation antibody-drug conjugates (ADCs) for the treatment of cancer. They utilize a proprietary platform to create highly potent and selective ADCs, aiming for improved efficacy and safety in oncology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.